| Literature DB >> 30291124 |
.
Abstract
Scientists have identified a wide variety of challenges preventing the development of effective CAR T-cell therapies for solid tumors, but they are investigating just as many potential solutions. Progress has been slow, but many researchers remain optimistic that successful CAR T-cell therapies, either alone or in combination with other treatments, will eventually be developed. ©2018 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30291124 DOI: 10.1158/2159-8290.CD-ND2018-008
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397